Hepatect® CP 50 IU/ml solution for infusion
Human hepatitis B immunoglobulin for intravenous administration
Hepatect CP contains 50 mg/ml of human plasma protein consisting of at least 96% immunoglobulin G (IgG). The hepatitis B antibody content is 50 IU/ml. Hepatitis B is an inflammation of the liver caused by the hepatitis B virus. Hepatect CP is a solution for intravenous infusion and is available in 2 ml (100 International Units [IU]), 10 ml (500 IU), 40 ml (2000 IU), and 100 ml (5000 IU) vials.
Hepatect CP is used to provide immediate and long-term immunity to:
- Prevent hepatitis B infection in patients who have not been vaccinated or not fully vaccinated against hepatitis B and who are at risk for hepatitis B infection.
- Prevent infection of a transplanted liver in patients who have tested positive for hepatitis B.
- Protect newborns whose mothers are infected with the hepatitis B virus.
- Protect patients in whom hepatitis B vaccination has not provided adequate protection.
